Early Access — free while we kick the tires
EdgarHawk

VVOS Vivos Therapeutics, Inc. Insider Trading

Latest: Insider Bought $1.8M of Shares · Mar 2026
1 filing analyzed · Latest 2026-04-02
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
April 2026
2026-04-02
high
Skaff Michael C Buy
1,353,625 shares
$1,813,858
@ $1.34
Significance 7/10

10% owner Skaff buys 1,353,625 shares for $1,813,857.50 (2 txns at $1.34); stock -81.0% from 52-week high, company unprofitable

Michael C Skaff, a 10% owner, executed 2 separate purchases totaling 1,353,625 shares for $1,813,857.50 at $1.34/share on 2026-03-31. The company is operating at a significant loss ($-5,400,000 net income in the latest quarter) with minimal revenue ($6,783,000) relative to a market cap of $11,864,299.92. The stock has declined -81.0% from its 52-week high of $6.95 and stands at $1.32 currently, representing a -47.8% decline over the past 90 days. A substantial capital deployment by a 10% owner at a deeply depressed valuation in an unprofitable enterprise represents material insider activity that warrants investor scrutiny of the underlying business fundamentals and the basis for this acquisition.

Get alerts for VVOS

Add VVOS to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access